Clinical trial · Observational
Skin Cancer in Swiss Transplant Cohort Study
NCT02361229CI-TRIAL-00039760SCSTCSunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
It's known that organ transplant recipients with long-term drug-induced immunosuppression have a increase of the life-time incidence of squamous cell carcinoma. This study will analyze the incidence and type of skin cancer in the Swiss Transplant Cohort Study and the association with exposure to immunosuppressive and antiinfective drugs and other parameters like age or gender of organ transplant recipients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Skin Cancer | Malignant Skin Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Incidence of Skin Cancer in SOTRs
- timeFrame
- 10 years
- description
- skin cancer event
- measure
- Incidence and type of skin neoplasms in STORs
- timeFrame
- 10 years
- description
- skin neoplasm event
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 1 Hour
Show eligibility criteria text
Inclusion Criteria: * solid organ transplant recipients within the STCS * patients with multiple organ transplantations will be included as well * patients within the STCS, who gave the informed consent to use their data * patients with graft loss will remain in the study, since they remain at risk of skin cancer development Exclusion Criteria: * organ transplant recipients of non-solid organs (e.g. hematopoetic stem cell transplantation) within the STCS
References
Publications (0)
Data not yet available
No reference posted for this study.